Primary Site >> Pancreatic Cancer

Gene >> KRT6A

Journal: Int J Cancer. 1992 Nov 11;52(5):827-33.
Title: Expression and function of VLA-alpha 2, -alpha 3, -alpha 5 and -alpha 6-integrin receptors in pancreatic carcinoma.
Author: Weinel, R J|Rosendahl, A|Neumann, K|Chaloupka, B|Erb, D|Rothmund, M|Santoso, S
PMID: 1330937
Journal: Mol Pharmacol. 1999 Sep;56(3):515-25.
Title: Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A.
Author: Rajesh, D|Schell, K|Verma, A K
PMID: 10462539
Journal: Sci Rep. 2014 Dec 18;4:7546.
Title: MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.
Author: Wei, Yongbao|Yang, Jinrui|Yi, Lu|Wang, Yinhuai|Dong, Zhitao|Liu, Ziting|Ou-yang, Shifeng|Wu, Hongtao|Zhong, Zhaohui|Yin, Zhuo|Zhou, Keqin|Gao, Yunliang|Yan, Bin|Wang, Zhao
PMID: 25519054
Journal: Bioorg Med Chem Lett. 2016 Dec 1;26(23):5703-5706.
Title: Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.
Author: Wang, Yiqiang|Hedblom, Andreas|Koerner, Steffi K|Li, Mailin|Jernigan, Finith E|Wegiel, Barbara|Sun, Lijun
PMID: 27810244
Journal: PLoS One. 2018 Aug 9;13(8):e0201751.
Title: Pancreatic cancer survival analysis defines a signature that predicts outcome.
Author: Raman, Pichai|Maddipati, Ravikanth|Lim, Kian Huat|Tozeren, Aydin
PMID: 30092011